ID Advocacy in Action: Shaping Policy Ahead of the Midterms

ID Advocacy in Action: Shaping Policy Ahead o...

Up next

When Adventure Meets Infectious Diseases

Paul Sax, MD, FIDSA sits down with comedy-writer, Mike Reiss, and his wife, Denise Reiss, to discuss a lifetime of travel experiences spanning more than 100 countries. From submarine dives and whale sharks to a hospitalization caused by Shigella, they recount remarkable adventure ...  Show more

Building HIV Care in Rural America

Host Mati Hlatshwayo Davis, MD, MPH, FIDSA, is joined by Darrell McBride, DO, FIDSA, former program director and founder of the Geisinger Ryan White Program, to discuss the realities of delivering HIV and infectious diseases care in rural communities. They explore barriers to car ...  Show more

Recommended Episodes

Public Health in an Era of Endemic COVID-19
Healthy Dialogue

Three members of President Biden's former COVID-19 Advisory Board—Luciana Borio, MD, Ezekiel Emanuel, MD, PhD, and Mike Osterholm, PhD—discuss their recent JAMA Viewpoints, providing their ideas on strategies for public health as COVID-19 transitions from pandemic to endemic. ...

  Show more

117: They Paged Me What? A TID Guide to Donor Call
Febrile

Drs. Chelsea Gorsline, Courtney Harris, and Rebecca Kumar join to tell us more about the Transplant ID Early Career Network and how to approach donor call!Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.comFebrile is produced with support from the In ...  Show more

119: Old Scourges, New Surges
Febrile

Dr. Adam Ratner joins to discuss a case of facial swelling which leads to a conversation about vaccine hesitancy and current outbreaks.Check out Booster Shots: The Urgent Lessons of Measles and the Uncertain Future of Children’s Health ! Episodes | Consult Notes | Subscribe | Twi ...  Show more

COVID-19 Update: Omicron Variant
Healthy Dialogue

Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a 2021-2022 "twindemic" with flu, and the latest COVID-19 clinical updates. Rec ...

  Show more